This inventor holds 2 USPTO granted patents. Top assignees: University of California, The University of Texas System. Active years: 1996-1999.
Location History:
- Los Angeles, CA (US) (1996)
- South Laguna, CA (US) (1999)
Company Filing History:
2 out of 15,988 
1 out of 5,630 
Years Active: 1996-1999
Title: The Innovative Contributions of Ernest P. Noble
Introduction
Ernest P. Noble, an esteemed inventor based in Los Angeles, CA, has made significant strides in the field of medical research, specifically concerning alcohol addiction and compulsive disorders. With two patents to his name, his inventions showcase a deep understanding of the connections between genetics and behavioral health.
Latest Patents
Noble's latest patents include groundbreaking work on the use of bromocriptine for treating alcoholics diagnosed with the D.sub.2 receptor gene variant. This invention details a novel approach utilizing dopamine agonists and opioidergic compositions to aid individuals battling alcoholism. The therapeutic methods described in this patent particularly focus on patients with the A1 allele of the dopamine receptor D2 gene, offering hope through advanced therapeutic kits.
Noble’s other patent concerns a method for diagnosing susceptibility to compulsive disorders through DNA analysis. This method involves the detection of specific human D.sub.2 receptor gene alleles, which serve as indicators of an individual’s predisposition to various compulsive behaviors, including alcoholism and substance abuse. This innovative approach could revolutionize the diagnosis and treatment of disorders that affect countless individuals globally.
Career Highlights
Noble's career has been marked by prestigious affiliations with notable institutions, including the University of California and the University of Texas System. His dedication to research and development in the fields of genetics and addiction has established him as a pivotal figure in his domain.
Collaborations
Throughout his career, Noble has had the opportunity to collaborate with prominent figures in the field, including Kenneth J. Blum and Peter J. Sheridan. These partnerships have fostered an environment of shared knowledge and innovation, propelling his research forward and enhancing the impact of his patents.
Conclusion
Ernest P. Noble's contributions to the understanding of addiction and compulsive disorders through his innovative patents underline the importance of genetic research in developing effective treatments. His work not only paves the way for future discoveries in the field but also offers hope for those affected by these challenging conditions.